GSA CAPITAL PARTNERS LLP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$586
-12.3%
195,415
-28.0%
0.05%
-25.4%
Q2 2023$668
+373.8%
271,524
+333.8%
0.07%
+378.6%
Q1 2023$141
-67.1%
62,598
-48.9%
0.01%
-73.6%
Q4 2022$428
-99.9%
122,590
+603.4%
0.05%
+8.2%
Q4 2021$393,00017,4290.05%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders